| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
1,816
|
1,400
|
1,210
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
1,816
|
1,400
|
1,210
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 871 | 875 | 795 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 281 | 157 | 29 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
664
|
369
|
386
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 28 | 79 | 156 |
|
Earnings Before Interest And Taxes | 692 | 448 | 542 |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | 692 | 448 | 542 |
|
Income Tax Expense | 303 | 192 | 223 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 389 | 257 | 319 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
389
|
257
|
319
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
389
|
257
|
319
|
|